WatchMedium Impact
Employer GLP-1 coverage pullback becomes a cash-pay watch item
Reuters reported that some U.S. employers are planning to drop GLP-1 obesity-drug coverage in 2027 as utilization increases.
Operator impact: Clinics should prepare for more patients seeking cash-pay alternatives, branded cash-pay navigation, maintenance care, and medically supervised programs that are not just vial fulfillment.
WatchMedium Impact
U.S. med spa market growth remains a major cash-pay tailwind
AmSpa's 2026 industry materials describe a medical aesthetics industry that has eclipsed $17 billion in revenue and is growing by more than $1 billion per year.
Operator impact: Growth remains strong, but increased competition means operators need sharper positioning, documented safety, better retention systems, and more disciplined service-line economics.